Synthesis and Anticonvulsant Activity of 1-Formamide-triazolo[4,3a]quinoline Derivatives

被引:25
作者
Wei, Cheng-Xi [1 ,2 ]
Deng, Xian-Qing [2 ]
Chai, Kyu-Yun [3 ]
Sun, Zhi-Gang [1 ]
Quan, Zhe-Shan [2 ]
机构
[1] Inner Mongolia Univ Nationalities, Inst Neurosurg, Tongliao 028007, Inner Mongolia, Peoples R China
[2] Yanbian Univ, Coll Pharm, Yanji 133000, Jilin, Peoples R China
[3] Wonkwang Univ, Dept Chem, Iksan 570749, South Korea
关键词
Synthesis; Triazole; Quinoline; Formamide; Anticonvulsant; Toxicity; ANTIEPILEPTIC DRUG DEVELOPMENT; AGENTS; DESIGN;
D O I
10.1007/s12272-010-0502-0
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Using 6-hydroxy-3,4-dihydro-2(1H)-quinolone as the starting material, a series of 1-formamide-triazolo[4, 3-a]quinoline derivatives (6a-6n) was synthesized, the anticonvulsant effect and neurotoxicity of the compounds was calculated with maximal electroshock test and rotarod tests with intraperitoneally injected in KunMing mice. The results demonstrated that compound 7-(hexyloxy)-4,5-dihydro-[1,2,4] triazolo[4,3-a] quinoline-1-carboxamide (6d) was the most active one and also had the lowest toxicity. In the anti-maximal electroshock potency test, it showed median effective dose (ED50) of 30.1 mg/kg, median toxicity dose (TD50) of 286 mg/kg, and the protective index of 9.5 which is greater than the reference drug carbamazepine with the protective index value of 6.0.
引用
收藏
页码:655 / 662
页数:8
相关论文
共 15 条
[1]   Synthesis and properties of new substituted 1,2,4-triazoles: Potential antitumor agents [J].
Al-Soud, YA ;
Al-Masoudi, NA ;
Ferwanah, AERS .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (08) :1701-1708
[2]   Synthesis and anticonvulsant activity of 1-substituted-7-benzyloxy-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline [J].
Cui, LJ ;
Xie, ZF ;
Piao, HR ;
Li, G ;
Chai, KY ;
Quan, ZS .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (07) :1216-1220
[3]  
Gasior M, 1997, J PHARMACOL EXP THER, V282, P543
[4]   ANTIEPILEPTIC DRUG DEVELOPMENT .2. ANTICONVULSANT DRUG SCREENING [J].
KRALL, RL ;
PENRY, JK ;
WHITE, BG ;
KUPFERBERG, HJ ;
SWINYARD, EA .
EPILEPSIA, 1978, 19 (04) :409-428
[5]  
Leppik IE, 1994, EPILEPSIA, V35, P29
[6]  
Lin ZW, 1997, MED RES REV, V17, P537, DOI 10.1002/(SICI)1098-1128(199711)17:6<537::AID-MED3>3.0.CO
[7]  
2-2
[9]   ANTIEPILEPTIC DRUG DEVELOPMENT PROGRAM [J].
PORTER, RJ ;
CEREGHINO, JJ ;
GLADDING, GD ;
HESSIE, BJ ;
KUPFERBERG, HJ ;
SCOVILLE, B ;
WHITE, BG .
CLEVELAND CLINIC QUARTERLY, 1984, 51 (02) :293-305
[10]  
Quan ZS, 2005, B KOREAN CHEM SOC, V26, P1757